微创与开放远端胰腺切除术选择及结局的国际差异:跨大西洋分析
基于四个GAPASURG登记库2014-2020年20158例远端胰腺切除术的回顾性分析,微创手术占36%,各登记库使用率29%-54%,机器人手术占13%-35%。微创组患者更年轻、女性更多、BMI更高、合并症分类更低、胰腺腺癌比例更低。
要点
- 微创远端胰腺切除术使用率在四个登记库间差异大(29%-54%),荷兰最高。
- 微创组患者选择偏向年轻、女性、高BMI、低合并症及低胰腺腺癌比例。
核心结论
- 四个跨大西洋胰腺手术登记库中微创远端胰腺切除术使用率存在显著差异。
- 总体微创远端胰腺切除术与开放手术相比30天死亡风险更低。
- 各国患者选择差异可能反映处于学习曲线的不同阶段。
研究设计与样本
- 回顾性队列研究,纳入四个GAPASURG登记库2014-2020年所有远端胰腺切除术患者。
- 共纳入20158例远端胰腺切除术,其中7316例(36%)为微创手术。
主要发现
- 微创远端胰腺切除术使用率在各登记库间为29%至54%,其中机器人手术占13%至35%。
- 微创组患者更年轻(德国和瑞典)、女性更多(北美和德国)、BMI更高(北美、荷兰、德国)、合并症分类更低(北美、德国、瑞典)、体能状态更低(德国)、胰腺腺癌比例更低(所有)。
- 微创组血管切除更少(所有),严重并发症和死亡率更低(北美和德国)。
- 多变量回归中,国家与严重并发症相关但与30天死亡率无关。
临床怎么用
- 临床选择微创远端胰腺切除术时需考虑患者年龄、性别、BMI、合并症及肿瘤病理类型。
- 应关注各国使用率差异及学习曲线阶段对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The efficacy and safety of minimally invasive distal pancreatectomy have been confirmed by randomized trials, but current patient selection and outcome of minimally invasive distal pancreatectomy in large international cohorts is unknown. This study aimed to compare the use and outcome of minimally invasive distal pancreatectomy in North America, the Netherlands, Germany, and Sweden. METHODS: All patients in the 4 Global Audits on Pancreatic Surgery Group (GAPASURG) registries who underwent minimally invasive distal pancreatectomy or open distal pancreatectomy during 2014-2020 were included. RESULTS: Overall, 20,158 distal pancreatectomies were included, of which 7,316 (36%) were minimally invasive distal pancreatectomies. Use of minimally invasive distal pancreatectomy varied from 29% to 54% among registries, of which 13% to 35% were performed robotically. Both the use of minimally invasive distal pancreatectomy and robotic surgery were the highest in the Netherlands. Patients undergoing minimally invasive distal pancreatectomy tended to have a younger age (Germany and Sweden), female sex (North America, Germany), higher body mass index (North America, the Netherlands, Germany), lower comorbidity classification (North America, Germany, Sweden), lower performance status (Germany), and lower rate of pancreatic adenocarcinoma (all). The minimally invasive distal pancreatectomy group had fewer vascular resections (all) and lower rates of severe complications and mortality (North America, Germany). In the multivariable regression analysis, country was associated with severe complications but not with 30-day mortality. Minimally invasive distal pancreatectomy was associated with a lower risk of 30-day mortality compared with open distal pancreatectomy (odds ratio 1.633, 95% CI 1.159-2.300, P = .005). CONCLUSIONS: Considerable disparities were seen in the use of minimally invasive distal pancreatectomy among 4 transatlantic registries of pancreatic surgery. Overall, minimally invasive distal pancreatectomy was associated with decreased mortality as compared with open distal pancreatectomy. Differences in patient selection among countries could imply that countries are in different stages of the learning curve.
引用
- Johansen KU, Augustinus S, Wellner UF, et al. International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis. Surgery. 2024. PMID: 39019733. doi:10.1016/j.surg.2024.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。